Showing results (51-60 of 96) with videos related to
Sort By:
Pageof 10
Journal of Medicinal Chemistry|April 26, 2000
Synthesis, spectroscopy, and cytotoxicity of glycosylated acetogenin derivatives as promising molecules for cancer therapyE F Queiroz, F Roblot, P Duret, et al.Blood|May 1, 1992
Is 600 mg/m2 the appropriate dosage of busulfan in children undergoing bone marrow transplantation?G Vassal, A Deroussent, D Challine, et al.Journal of Chromatography|March 27, 1992
Simultaneous determination of the camptothecin analogue CPT-11 and its active metabolite SN-38 by high-performance liquid chromatography: application to plasma pharmacokinetic studies in cancer patientsI Barilero, D Gandia, J P Armand, et al.The Journal of Biological Chemistry|August 25, 1989
Mechanism of cleavage of apurinic sites by 9-aminoellipticineJ R Bertrand, J J Vasseur, A Gouyette, et al.Cancer Research|November 15, 1988
Cytoplasmic accumulation of ditercalinium in rat hepatocytes and induction of mitochondrial damageR Fellous, D Coulaud, I el Abed, et al.Cancer Treatment Reports|August 1, 1980
Metabolism and disposition studies of 9-hydroxyellipticine and 2-methyl-9-hydroxyellipticinium acetate in animalsN Van-Bac, C Moisand, A Gouyette, et al.Cancer Treatment Reports|July 1, 1981
Kinetics of cisplatin in an anuric patient undergoing hemofiltration dialysisA Gouyette, R Lemoine, J P Adhemar, et al.Cancer|August 1, 1994
Verapamil-reversing concentrations induce blood flow changes that could counteract in vivo the MDR-1-modulating effectsL H Ramirez, J N Munck, Z Zhao, et al.Lung Cancer (Amsterdam, Netherlands)|August 1, 1995
Phase I-II and pharmacokinetic study of a new fotemustine schedule in advanced non-small cell lung cancerA Le Cesne, G Chabot, J Bérille, et al.Cancer Research|August 1, 1993
Main drug-metabolizing enzyme systems in human breast tumors and peritumoral tissuesN Albin, L Massaad, C Toussaint, et al.Pageof 10